KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2025)

Bionano Genomics' Other Non Operating Income history spans 7 years, with the latest figure at -$218000.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 68.72% year-over-year to -$218000.0; the TTM value through Sep 2025 reached -$2.9 million, up 87.0%, while the annual FY2024 figure was -$10.1 million, 50.71% up from the prior year.
  • Other Non Operating Income for Q3 2025 was -$218000.0 at Bionano Genomics, down from $676000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $5.1 million in Q1 2025 and bottomed at -$20.4 million in Q4 2023.
  • The 5-year median for Other Non Operating Income is -$40000.0 (2022), against an average of -$1.4 million.
  • The largest annual shift saw Other Non Operating Income plummeted 50860.0% in 2023 before it surged 473.25% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $2.0 million in 2021, then plummeted by 101.98% to -$40000.0 in 2022, then tumbled by 50860.0% to -$20.4 million in 2023, then skyrocketed by 58.75% to -$8.4 million in 2024, then skyrocketed by 97.41% to -$218000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Other Non Operating Income are -$218000.0 (Q3 2025), $676000.0 (Q2 2025), and $5.1 million (Q1 2025).